A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer

Aim: Response Evaluation Criteria in Solid Tumors (RECIST) is occasionally insufficient for evaluation. We proposed a new prognostic index (NPI) that combines the standardized uptake value (SUV), metabolic tumor volume (MTV), and RECIST. Methods: In total, 116 patients with lung cancer who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wenfang, Hou, Qingyi, Lin, Juntao, Li, Dongjiang, Lin, Jieshan, Chen, Jinghua, Qiu, Zhenbin, Chu, Xiangpeng, Yang, Xiongwen, Yan, Honghong, Wang, Shuxia, Wu, Yilong, Zhong, Wenzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493745/
https://www.ncbi.nlm.nih.gov/pubmed/33014793
http://dx.doi.org/10.3389/fonc.2020.01503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493745/
https://www.ncbi.nlm.nih.gov/pubmed/33014793
http://dx.doi.org/10.3389/fonc.2020.01503

Ejemplares similares